These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36288327)

  • 1. Remdesivir does not affect mitochondrial DNA copy number or deletion mutation frequency in aged male rats: A short report.
    Herbst A; Choi S; Hoang AN; Kim C; Martinez Moreno D; McKenzie D; Aiken JM; Wanagat J
    PLoS One; 2022; 17(10):e0271850. PubMed ID: 36288327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remdesivir increases mtDNA copy number causing mild alterations to oxidative phosphorylation.
    DeFoor N; Paul S; Li S; Basso EKG; Stevenson V; Browning JL; Prater AK; Brindley S; Tao G; Pickrell AM
    Sci Rep; 2023 Sep; 13(1):15339. PubMed ID: 37714940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remdesivir; molecular and functional measures of mitochondrial safety.
    Bjork JA; Wallace KB
    Toxicol Appl Pharmacol; 2021 Dec; 433():115783. PubMed ID: 34740633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal muscle mitochondrial DNA copy number and mitochondrial DNA deletion mutation frequency as predictors of physical performance in older men and women.
    Herbst A; Prior SJ; Lee CC; Aiken JM; McKenzie D; Hoang A; Liu N; Chen X; Xun P; Allison DB; Wanagat J
    Geroscience; 2021 Jun; 43(3):1253-1264. PubMed ID: 33740224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1'-Ribose cyano substitution allows Remdesivir to effectively inhibit nucleotide addition and proofreading during SARS-CoV-2 viral RNA replication.
    Zhang L; Zhang D; Wang X; Yuan C; Li Y; Jia X; Gao X; Yen HL; Cheung PP; Huang X
    Phys Chem Chem Phys; 2021 Mar; 23(10):5852-5863. PubMed ID: 33688867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.
    Shannon A; Le NT; Selisko B; Eydoux C; Alvarez K; Guillemot JC; Decroly E; Peersen O; Ferron F; Canard B
    Antiviral Res; 2020 Jun; 178():104793. PubMed ID: 32283108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells.
    Nguyenla X; Wehri E; Van Dis E; Biering SB; Yamashiro LH; Zhu C; Stroumza J; Dugast-Darzacq C; Graham TGW; Wang X; Jockusch S; Tao C; Chien M; Xie W; Patel DJ; Meyer C; Garzia A; Tuschl T; Russo JJ; Ju J; Näär AM; Stanley S; Schaletzky J
    Sci Rep; 2022 Nov; 12(1):18506. PubMed ID: 36323770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection.
    Ye ZW; Yuan S; Chan JF; Zhang AJ; Yu CY; Ong CP; Yang D; Chan CC; Tang K; Cao J; Poon VK; Chan CC; Cai JP; Chu H; Yuen KY; Jin DY
    Emerg Microbes Infect; 2021 Dec; 10(1):291-304. PubMed ID: 33538646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remdesivir (GS-5734) in COVID-19 Therapy: The Fourth Chance.
    Moirangthem DS; Surbala L
    Curr Drug Targets; 2021; 22(12):1346-1356. PubMed ID: 33267759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.
    Williamson BN; Feldmann F; Schwarz B; Meade-White K; Porter DP; Schulz J; van Doremalen N; Leighton I; Yinda CK; Pérez-Pérez L; Okumura A; Lovaglio J; Hanley PW; Saturday G; Bosio CM; Anzick S; Barbian K; Cihlar T; Martens C; Scott DP; Munster VJ; de Wit E
    Nature; 2020 Sep; 585(7824):273-276. PubMed ID: 32516797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
    Wang Y; Zhang D; Du G; Du R; Zhao J; Jin Y; Fu S; Gao L; Cheng Z; Lu Q; Hu Y; Luo G; Wang K; Lu Y; Li H; Wang S; Ruan S; Yang C; Mei C; Wang Y; Ding D; Wu F; Tang X; Ye X; Ye Y; Liu B; Yang J; Yin W; Wang A; Fan G; Zhou F; Liu Z; Gu X; Xu J; Shang L; Zhang Y; Cao L; Guo T; Wan Y; Qin H; Jiang Y; Jaki T; Hayden FG; Horby PW; Cao B; Wang C
    Lancet; 2020 May; 395(10236):1569-1578. PubMed ID: 32423584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19.
    Aleissa MM; Silverman EA; Paredes Acosta LM; Nutt CT; Richterman A; Marty FM
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33139290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin Treatment in Old Rats and Effects on Mitochondrial Integrity.
    Herbst A; Hoang A; Kim C; Aiken JM; McKenzie D; Goldwater DS; Wanagat J
    Rejuvenation Res; 2021 Dec; 24(6):434-440. PubMed ID: 34779265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of remdesivir and favipiravir - the anti-Covid-19 agents mimicking purine RNA constituents.
    Al-Ardhi FM; Novotny L; Alhunayan A; Al-Tannak NF
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Mar; 166(1):12-20. PubMed ID: 34782799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of exercise intensity on copy number and mutations of mitochondrial DNA in gastrocnemus muscles in mice.
    Cao X; Zhao ZW; Zhou HY; Chen GQ; Yang HJ
    Mol Med Rep; 2012 Aug; 6(2):426-8. PubMed ID: 22614633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No effect of remdesivir or betamethasone on upper respiratory tract SARS-CoV-2 RNA kinetics in hospitalised COVID-19 patients: a retrospective observational study.
    Sourander B; Andersson LM; Brink M; Yilmaz A; Sundell N; Marklund E; Nilsson S; Lindh M; Robertson J; Gisslén M
    Infect Dis (Lond); 2022 Oct; 54(10):703-712. PubMed ID: 35708280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs Against Human Coronavirus 229E (HCoV-229E).
    Parang K; El-Sayed NS; Kazeminy AJ; Tiwari RK
    Molecules; 2020 May; 25(10):. PubMed ID: 32429580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-Target
    Xu Y; Barauskas O; Kim C; Babusis D; Murakami E; Kornyeyev D; Lee G; Stepan G; Perron M; Bannister R; Schultz BE; Sakowicz R; Porter D; Cihlar T; Feng JY
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33229429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
    Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.